Myeloma News and Research

RSS
Zika virus could be alternative for treatment of aggressive brain cancer

Zika virus could be alternative for treatment of aggressive brain cancer

Study reveals HCT as effective treatment for NHL patients regardless of age

Study reveals HCT as effective treatment for NHL patients regardless of age

CAR-T therapy saves life of cancer researcher

CAR-T therapy saves life of cancer researcher

Historic study involving Simmons Cancer Center shows effectiveness of CAR-T therapy

Historic study involving Simmons Cancer Center shows effectiveness of CAR-T therapy

UAMS Myeloma Institute expert compiles new book on Castleman disease

UAMS Myeloma Institute expert compiles new book on Castleman disease

Phototherapeutic technology shows potential as anti-cancer weapon

Phototherapeutic technology shows potential as anti-cancer weapon

Patients with monoclonal gammopathy at risk of developing cancer even after 30 years

Patients with monoclonal gammopathy at risk of developing cancer even after 30 years

Proteasome inhibitor treatment can lead to cardiovascular problems in multiple myeloma patients

Proteasome inhibitor treatment can lead to cardiovascular problems in multiple myeloma patients

Study finds barriers to stem cell transplant use among multiple myeloma patients from minority groups

Study finds barriers to stem cell transplant use among multiple myeloma patients from minority groups

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

Mayo Clinic researchers find emojis to be helpful in assessing patients' quality of life

Mayo Clinic researchers find emojis to be helpful in assessing patients' quality of life

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

Two immunotherapy approaches for multiple myeloma show hope

Two immunotherapy approaches for multiple myeloma show hope

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

Nearly 6% of cancers worldwide caused by diabetes and high BMI, study finds

Nearly 6% of cancers worldwide caused by diabetes and high BMI, study finds

Study unveils new immunotherapeutic target against multiple myeloma

Study unveils new immunotherapeutic target against multiple myeloma

New technique holds promise to screen cancer cells for drug susceptibility

New technique holds promise to screen cancer cells for drug susceptibility

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

‘Precision Medicine’ may not always be so precise when applied to diverse populations, study says

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Insights from NGLY1 deficiency could provide new approach to treat blood cancers

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy